IoM's Errant Committee
This article was originally published in RPM Report
Executive Summary
An Institute of Medicine committee offers its recommendations on addressing medication errors. Stakeholders are eager to embrace process improvements-but the committee is on a quest to encourage fundamental changes in the entire drug development enterprise.